findmyKOL
Clinical trialNCT03949283Active, not recruitingPhase 3Interventional

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

SponsorCordgenics, LLCEnrollment150Platinum-resistant Ovarian CancerRecurrent Ovarian Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Kaiser Permanente

    Los Angeles, California, United States

  • Miami Cancer Institute/baptist Health South Florida

    Miami, Florida, United States

  • Lsu Health Sciences Center

    New Orleans, Louisiana, United States

  • University of Cincinnati Cancer Institute

    Cincinnati, Ohio, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, United States

  • West Penn Hospital, Allegheny Health Network

    Pittsburgh, Pennsylvania, United States

  • Charleston Area Medical Center (camc)

    Charleston, West Virginia, United States

  • Edwards Comprehensive Cancer Center - Cabell Huntington Hospital

    Huntington, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jul 2019
Primary completion
30 Jun 2024
Completion
30 Dec 2024
Last update posted
22 Aug 2024
Registered enrollment
150
Registry id
NCT03949283

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.